BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33941569)

  • 1. When O Bites Back: Unrecognized Acute Hemolytic Reaction from Out-of-Group HLA-Compatible Platelet Transfusion.
    Pasion JO; Song LH; McCusker MG; Shimer L; Bryant A; McGann HL; Fontaine MJ
    Ann Clin Lab Sci; 2021 Mar; 51(2):267-270. PubMed ID: 33941569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
    Josephson CD; Castillejo MI; Grima K; Hillyer CD
    Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Easier said than done: ABO compatibility and D matching in apheresis platelet transfusions.
    Dunbar NM; Katus MC; Freeman CM; Szczepiorkowski ZM
    Transfusion; 2015 Aug; 55(8):1882-8. PubMed ID: 25757728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABO-incompatible platelets are associated with increased transfusion reaction rates.
    Malvik N; Leon J; Schlueter AJ; Wu C; Knudson CM
    Transfusion; 2020 Feb; 60(2):285-293. PubMed ID: 31912889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABO incompatible platelets: risks versus benefit.
    Dunbar NM; Ornstein DL; Dumont LJ
    Curr Opin Hematol; 2012 Nov; 19(6):475-9. PubMed ID: 22914587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal acute hemolytic transfusion reaction due to anti-B from a platelet apheresis unit stored in platelet additive solution.
    Balbuena-Merle R; West FB; Tormey CA; Hendrickson JE
    Transfusion; 2019 Jun; 59(6):1911-1915. PubMed ID: 30865314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion of platelets containing ABO-incompatible plasma: a survey of 3156 North American laboratories.
    Fung MK; Downes KA; Shulman IA
    Arch Pathol Lab Med; 2007 Jun; 131(6):909-16. PubMed ID: 17550318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions.
    Karafin MS; Blagg L; Tobian AA; King KE; Ness PM; Savage WJ
    Transfusion; 2012 Oct; 52(10):2087-93. PubMed ID: 22339320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets.
    Mair B; Benson K
    Transfusion; 1998 Jan; 38(1):51-5. PubMed ID: 9482394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incompatible crossmatch: First sign of a hemolytic transfusion reaction due to out-of-group platelet transfusion.
    Basu D; Basu S; Roy J; Reddy M; Chandy M; Bhaumik J
    Asian J Transfus Sci; 2019; 13(1):57-59. PubMed ID: 31360013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABO-mismatched transfusions are not over-represented in febrile non-haemolytic transfusion reactions to platelets.
    Yazer MH; Raval JS; Triulzi DJ; Blumberg N
    Vox Sang; 2012 Feb; 102(2):175-7. PubMed ID: 21781126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hemolytic transfusion reaction following ABO-mismatched platelet transfusion: Two case reports.
    Zulkeflee RH; Hassan MN; Hassan R; Saidin NIS; Zulkafli Z; Ramli M; Abdullah M; Iberahim S; Roslan W; Mohd Noor NH; Wan Ab Rahman WS
    Transfus Apher Sci; 2023 Jun; 62(3):103658. PubMed ID: 36805153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating safety and cost-effectiveness of platelets stored in additive solution (PAS-F) as a hemolysis risk mitigation strategy.
    Pagano MB; Katchatag BL; Khoobyari S; Van Gerwen M; Sen N; Rebecca Haley N; Gernsheimer TB; Hess JR; Metcalf RA
    Transfusion; 2019 Apr; 59(4):1246-1251. PubMed ID: 30592057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolysis following platelet transfusions from ABO-incompatible donors.
    Pierce RN; Reich LM; Mayer K
    Transfusion; 1985; 25(1):60-2. PubMed ID: 2578692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two platelet transfusion strategies to minimize ABO-nonidentical transfusion, outdating, and shortages using a computer-simulated "virtual blood bank".
    Jackups R; Kymes S
    Transfusion; 2015 Feb; 55(2):348-56. PubMed ID: 25178153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dilution is not the solution: acute hemolytic transfusion reaction after ABO-incompatible pooled platelet transfusion.
    Guarente J; Harach M; Gould J; Karp JK; Peedin AR
    Immunohematology; 2019 Sep; 35(3):91-94. PubMed ID: 31621366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolysis after ABO-incompatible platelet transfusions.
    Chow MP; Yung CH; Hu HY; Tzeng CH
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Aug; 48(2):131-4. PubMed ID: 1654184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients.
    Heal JM; Blumberg N; Masel D
    Blood; 1987 Jul; 70(1):23-30. PubMed ID: 3474041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.
    Sintnicolaas K; Löwenberg B
    Br J Haematol; 1996 Mar; 92(4):1005-10. PubMed ID: 8616059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of ABO-incompatible transfusion].
    Fujii Y
    Masui; 2011 Jan; 60(1):47-54. PubMed ID: 21348250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.